1. Gilead may be looking to buy oncology startup Forty-Seven —FDA announces that COVID-19 has caused its first US drug shortage — Passage Bio raises upsized $216M IPO — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Nsm with Integra

Discussion in 'TEI Biosciences' started by anonymous, Aug 29, 2015 at 9:12 PM.

  1. anonymous

    anonymous Guest

    So how was it? Is anyone still around?